HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Fundamental and clinical studies of T-1982 (cefbuperazone) in the field of obstetrics and gynecology].

Abstract
T-1982 (cefbuperazone), a new cephamycin antibiotic, was fundamentally and clinically studied. The following results were obtained. Serum and internal genital tissue levels of T-1982 were measured following intravenous injection or intravenous drip infusion of 1 g. High serum levels of more than 10 micrograms/ml and tissue levels of more than 5 micrograms/g were maintained for 3 hours after intravenous administration. Favourable transfer of T-1982 into the pelvic dead space exudate was observed. The exudate level attained its peak at 2 hours and was 14.6 micrograms/ml on average even at 8 hours after intravenous infusion. With its MIC values, T-1982 was considered to be bactericidal against many Gram-negative bacteria except Pseudomonas sp. A total of 4 cases comprising 2 with pyometra, 1 with pelveoperitonitis and 1 with endometritis complicated with pelveoperitonitis was treated with T-1982 at a dose of 1-2 g twice daily by intravenous drip infusion. The clinical response was excellent in 1 case and good in 2 cases. A case with pyometra due to S. faecalis did not respond to the therapy. Side effects and abnormal laboratory findings due to the drug were not noted.
AuthorsA Nakanishi, S Saito, M Shintani, I Shimamoto, M Ichijo, K Takashima, N Tamori
JournalThe Japanese journal of antibiotics (Jpn J Antibiot) Vol. 36 Issue 5 Pg. 1018-24 (May 1983) ISSN: 0368-2781 [Print] Japan
PMID6413727 (Publication Type: Journal Article)
Chemical References
  • Cephamycins
  • cefbuperazone
Topics
  • Adult
  • Aged
  • Cephamycins (metabolism, pharmacology)
  • Endometritis (drug therapy)
  • Enterococcus faecalis (drug effects)
  • Female
  • Humans
  • Klebsiella pneumoniae (drug effects)
  • Middle Aged
  • Peritonitis (drug therapy)
  • Uterus (analysis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: